Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,770
Closed -$539K 2161
2025
Q4
$539K Buy
+10,770
New +$518K 0.07% 364
2024
Q3
Sell
-7,947
Closed -$319K 3570
2024
Q2
$319K Buy
+7,947
New +$301K ﹤0.01% 1936
2022
Q2
Sell
-4,463
Closed -$219K 2804
2022
Q1
$219K Buy
+4,463
New +$226K 0.01% 1678
2017
Q2
Sell
-5,269
Closed -$216K 1150
2017
Q1
$216K Buy
+5,269
New +$220K 0.04% 598

Other funds holding SNV

Two Sigma Securities's SNV Position: Q1 2026 in Review

Two Sigma Securities sold out of Synovus (SNV) in Q1 2026, closing a stake of 10,770 shares — an estimated $539K sold.

Two Sigma Securities first reported a position in SNV in Q1 2017 and held it in 4 quarters. The position peaked at $539K in Q4 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Two Sigma Securities reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 10,770 Synovus shares in Q1 2026, an estimated $539K.
  • Two Sigma Securities first reported a position in Synovus in Q1 2017 and held it in 4 quarters.
  • Two Sigma Securities's Synovus position peaked at $539K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.